{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:15:27Z","timestamp":1780521327274,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> In view of the high morbidity and mortality of Diabetes mellitus\u2014Coronary heart disease (DM-CHD) in diabetics, the combination therapy of traditional Chinese medicine injections (TCMIs) and conventional therapy (CT) is receiving extensive attention. Therefore, the effectiveness and security of conventional therapy with traditional Chinese medicine injections in the therapy of diabetes mellitus\u2014coronary heart disease were compared by systematical review and network meta-analysis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> According to the preset inclusion criteria and exclusion criteria, we searched seven electronic literature databases from their inception to JAN 5,2022, to obtain the relevant RCT literature on the therapy of diabetes mellitus\u2014coronary heart disease with traditional Chinese medicine injections. Two researchers independently reviewed the papers, two other researchers worked in extracting data and quality assessment of the included literature. The primary outcomes were total effective rate. The secondary outcomes included electrocardiogram (EGG)effective rate, the effective rate of angina pectoris, fasting blood glucose (FBG), 2-h postprandial blood glucose (PBG), hemoglobinA1c (HbA1c), total cholesterol (TC) and triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), frequency of angina pectoris, and duration of angina pectoris. We adopted stata16.0 software for the systematic review and network meta-analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 53 trials involved 4,619 patients and one of the following 16 traditional Chinese medicine injections: Danhong, Danshen, Gualoupi, Gegen, Chuanxiongqin, Danshenchuanxiongqin, Shenmai, Shenqi, Xixin, Xuesaitong, Shuxuetong, Guanxinning, Kudiezi, Ciwujia, Xingding, Shuxuening. The meta-analysis revealed that Chuanxiongqin injection was superior to all other therapies in improving the total effective rate, [vs. conventional therapy odds ratio (OR): 14.52, 95% confidence interval (CI): 4.13\u201351.02], vs. Xuesaitong injection (odds ratio: 7.61, confidence interval: 1.25\u201346.40), and vs. Danshenchuanxiongqin injection (odds ratio: 3.98, confidence interval: 1.03\u201315.28)]. Xixin injection + conventional therapy was superior to conventional therapy only for electrocardiogram effective rate (odds ratio: 5.44, confidence interval: 1.55\u201319.18). Shenmai injection + conventional therapy was superior to conventional therapy in effective rate of angina (odds ratio: 11.05, confidence interval: 2.76\u201344.28). There was not different significantly in the comparisons of frequency of angina pectoris and duration of angina pectoris, we considered that this may be due to the lack of sufficient data. As most of the included RCTs did not monitor Adverse Events, the safety of those traditional Chinese medicine injections remains to be further explored.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Basing on our study, traditional Chinese medicine injections combined with conventional therapy takes important role in the treatment of diabetes mellitus\u2014coronary heart disease, and its curative effect is better than conventional therapy. Nevertheless, properly designed RCTs are required to validate our conclusions in the future.<\/jats:p><jats:p><jats:bold>Systematic Review Registration<\/jats:bold>: [<jats:ext-link>https:\/\/inplasy.com\/inplasy-2021-12-0125\/<\/jats:ext-link>], identifier [INPLASY2021120125].<\/jats:p>","DOI":"10.3389\/fphar.2022.1060956","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T09:41:07Z","timestamp":1673257267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness and safety of selected traditional Chinese medicine injections in patients with combined diabetes mellitus and coronary heart disease: A systematic review and network meta-analysis of randomized clinical trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Hailiang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jep.2016.10.025","article-title":"Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by danhong injection are critically contributed by anti-TGF-\u03b2-mediated fibrosis and angiogenesis mechanisms","volume":"194","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/joor.12540","article-title":"Network meta-analysis","volume":"44","author":"De Laat","year":"2017","journal-title":"J. Oral Rehabil."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6650763","DOI":"10.1155\/2022\/6650763","article-title":"Systematic review of the efficacy and safety of shuxuening injection in the treatment of unstable angina","volume":"2022","author":"Fan","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese medicine for cardiovascular disease: Evidence and potential mechanisms","volume":"69","author":"Hao","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/DMSO.S188705","article-title":"Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials","volume":"12","author":"Hinnen","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jep.2015.08.026","article-title":"Bioactivity-integrated UPLC\/Q-TOF-MS of Danhong injection to identify NF-\u03baB inhibitors and anti-inflammatory targets based on endothelial cell culture and network pharmacology","volume":"174","author":"Jiang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1055\/s-0034-1366278","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"122","author":"Kerner","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"972738","DOI":"10.3389\/fphar.2022.972738","article-title":"Efficacy and safety of eight types salvia miltiorrhiza injections in the treatment of unstable angina pectoris: A network meta-analysis","volume":"2022","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5814749","DOI":"10.1155\/2019\/5814749","article-title":"Efficacy of danshen class injection in the treatment of acute cerebral infarction: A bayesian network meta-analysis of randomized controlled trials","volume":"2019","author":"Liu","year":"2019","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/j.ihj.2018.11.017","article-title":"Incidence of new diabetes following CABG surgery: Analysis of a single centre registry data","volume":"70","author":"Lodha","year":"2018","journal-title":"Indian Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.17-191","article-title":"Coronary artery disease and type 2 diabetes mellitus","volume":"58","author":"Naito","year":"2017","journal-title":"Int. Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1055\/a-1018-9078","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"127","author":"Petersmann","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.13422\/j.cnki.syfjx.2015100195","article-title":"Mechanism of action of Shenmai injection as an adjunct to thrombolysis in acute ST segment elevation myocardial infarction","volume":"21","author":"Qi","year":"2015","journal-title":"Chin. J. Exp. formulas"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00228-014-1668-z","article-title":"Identifying high-risk medication: A systematic literature review","volume":"70","author":"Saedder","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition","volume":"9157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3760\/cma.j.issn.0253-3758.2018.09.004","article-title":"Guidelines for the diagnosis and treatment of stable coronary heart disease","volume":"46","author":"Wang","year":"2018","journal-title":"Chin. J. Cardiovasc. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.13288\/j.11-2166\/r.2019.04.003","article-title":"Connotation and extension of the theory of phlegm-blood stasis-stagnation-deficiency in coronary heart disease","volume":"60","author":"Wang","year":"2019","journal-title":"J. Traditional Chin. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018","volume":"326","author":"Wang","year":"","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jep.2017.04.027","article-title":"Danshen injection prevents heart failure by attenuating post-infarct remodeling","volume":"205","author":"Wang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1248\/cpb.c20-00122","article-title":"Systems pharmacology dissection of mechanisms of dengzhan Xixin injection against cardiovascular diseases","volume":"68","author":"Wang","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"B27","doi-asserted-by":"publisher","first-page":"625785","DOI":"10.3389\/fphar.2021.625785","article-title":"Design and methodology of a multicenter randomized clinical trial to evaluate the efficacy of tongmai jiangtang capsules in type 2 diabetic coronary heart disease patients","volume":"12","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","article-title":"Cardiomyocyte -specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12872-019-1016-4","article-title":"Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Cardiovasc Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3969\/j.issn.1674-1749.2017.05.037","article-title":"A review of TCM pattern correlation in type 2 diabetes and coronary heart disease","volume":"10","author":"Yang","year":"2017","journal-title":"Univers. Tradit. Chin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.16662\/j.cnki.1674-0742.2021.09.086","article-title":"Effect of Erigeron Breviscapus Injection on angina pectoris of coronary heart disease","volume":"40","author":"Ye","year":"2021","journal-title":"Drugs Clin."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3969\/j.issn.1005-9202.2021.04.006","article-title":"Clinical characteristics and biochemical indexes of patients with coronary heart disease complicated with type 2 diabetes","volume":"41","author":"Yu","year":"2021","journal-title":"Chin. J. Gerontology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3969\/j.issn.1001-1528.2016.05.006","article-title":"Effects of Shuxuetong Injection on hemorheology, platelet activation function and myocardial injury after PCI in patients with unstable angina","volume":"38","author":"Zhang","year":"2016","journal-title":"Chin. Pat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1055\/s-0032-1328588","article-title":"Salvia miltiorrhiza (Danshen) injection ameliorates iron overload-induced cardiac damage in mice","volume":"79","author":"Zhang","year":"2013","journal-title":"Planta Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.7150\/thno.48561","article-title":"Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11655-008-0281-3","article-title":"Effect of Shengmai injection on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus","volume":"14","author":"Zhang","year":"2008","journal-title":"Chin. J. Integr. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.16367\/j.issn.1003-5028.2017.12.0726","article-title":"Gualoupi injection in type 2 diabetes mellitus with coronary heart disease chronic heart failure 40 patients","volume":"37","author":"Zhou","year":"2017","journal-title":"Henan Tradit. Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1060956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T09:41:18Z","timestamp":1673257278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1060956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.1060956"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1060956","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1060956"}}